Dual-eligible, dual-risk? A brief review on the impact of dual-eligible status on health disparities and peripheral artery disease

Semin Vasc Surg. 2023 Mar;36(1):64-68. doi: 10.1053/j.semvascsurg.2022.12.005. Epub 2022 Dec 28.

Abstract

Peripheral artery disease (PAD) has been associated with poorer outcomes based on particular social determinants of health, including insurance status. A unique population to study treatment outcomes related to PAD is those with dual-eligible status-those who qualify for both Medicare and Medicaid-comprising more than 12 million people. We performed a systematic review of the literature surrounding dual-eligible patients and impact on PAD, with final inclusion of six articles. Dual eligibility has been associated with higher rates of comorbidities; more severe symptoms at initial presentation for PAD; and poorer treatment outcomes, including mortality. Further studies are needed to specifically look at the association between PAD and dual-eligible status, but what is clear is that patients in this population would benefit from early identification to prevent disease progression and improve equity.

Keywords: Dual-eligible status; Health disparities; Peripheral artery disease; Social determinants of health.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Aged
  • Comorbidity
  • Humans
  • Medicaid
  • Medicare*
  • Peripheral Arterial Disease* / diagnosis
  • Peripheral Arterial Disease* / epidemiology
  • Peripheral Arterial Disease* / therapy
  • Risk Assessment
  • United States / epidemiology